PolyPid (PYPD)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $132.25M
Last updated: Nov 17, 2026 at 11:05 AM ET
PolyPid (PYPD) Stock Forecast
Analysts expect PolyPid (PYPD) to earn $0.10 per share in the fiscal year ending Dec 31, 2026, on revenue of $21.05M. Of 5 analysts, 5 rate the stock Buy or Strong Buy, 0 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 1 estimate for the fiscal year ending Dec 31, 2026 was revised up and 0 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 5 ratings average 1.80, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 100% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 1 | 20.0% |
| Buy | 4 | 80.0% |
| Hold | 0 | 0.0% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 5
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus turns from a profit to a loss and revenue estimates fall 54.1%.
- Fiscal year ending Dec 31, 2026
- $0.10
- EPS consensus, revenue $21.05M
- Fiscal year ending Dec 31, 2027
- -$0.96
- EPS consensus, revenue $9.67M
- Next report
- Feb 9, 2027
- Estimated
EPS range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $0.10 | -$0.17 to $0.52 | 3 | $21.05M | N/A | 5 |
| Dec 31, 2027 | -$0.96 | -$1.82 to -$0.32 | 5 | $9.67M | $2.80M to $13.64M | 5 |
Quarterly Estimates
| Quarter ending | EPS consensus | EPS range | EPS analysts |
|---|---|---|---|
| Dec 31, 2026 | -$0.41 | -$0.55 to -$0.30 | 7 |
Estimate Revisions
Across the 2 periods below, the last 30 days brought 3 upward and 2 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 1 | 0 |
| Fiscal year ending Dec 31, 2027 | 2 | 2 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has turned from a loss of $0.89 to a profit.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | $0.10 | -$0.61 | -$0.89 | -$0.89 | -$0.89 | N/A |
| Fiscal year ending Dec 31, 2027 | -$0.96 | -$1.05 | -$1.23 | -$1.23 | -$1.23 | N/A |
Frequently Asked Questions About PYPD
What is the PYPD stock forecast?
Consensus analyst estimates put PolyPid's EPS at $0.10 for the fiscal year ending Dec 31, 2026, on revenue of $21.05M. The consensus rating from 5 analysts is Buy.
How do analysts rate PYPD stock?
Of 5 analysts covering PolyPid, 1 rates it Strong Buy, 4 Buy, 0 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from PYPD next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $0.10, with estimates from -$0.17 to $0.52 from 3 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$0.96, with estimates from -$1.82 to -$0.32 from 5 analysts.
What revenue do analysts expect from PolyPid next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $21.05M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $9.67M, with estimates from $2.80M to $13.64M.
How many analysts cover PYPD?
5 analysts rate PolyPid stock, and 3 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
PYPD pages: Overview, Earnings, Forecast, Competitors